About ImmunoPrecise Antibodies Ltd
ImmunoPrecise Antibodies, Ltd (IPA) is an industry leading, CRO, providing single-source therapeutic antibody discovery services featuring B cell Select, Phage Display, and Hybridoma platforms. IPA an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell technology and the DeepDisplay™ custom phage libraries, as well as the Abthena™ bispecific program. All of these technologies integrate seamlessly with IPA’s integrated Artemis™ Intelligence Metadata (AIM)™ capabilities to enable rapid turnaround on additional outputs in therapeutic optimization, stability, affinity, and manufacturability.
State of Ownership